Article

Drug screening targeting TREM2-TYROBP transmembrane binding

2024-12-02

Abstract excerpt

TREM2 encodes a microglial membrane receptor involved in the disease-associated microglia (DAM) phenotype whose activation requires the transmembrane interaction with TYROBP. Mutations in TREM2 represent a high-impact risk factor for Alzheimer’s disease (AD) which turned TREM2 into a significant drug target. We present a bacterial two-hybrid (B2H) system designed for high-throughput screening of modulators for th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b5a3d8f3-feac-525b-b4eb-877aaaee976b
DOI: 10.1101/2024.12.02.626344

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug screening targeting TREM2-TYROBP transmembrane bindingDOI 10.1101/2024.12.02.626344Read

Drug screening targeting TREM2-TYROBP transmembrane bindingSemantic proximity Read

AI-Assisted Discovery and Optimization of Small Molecule TREM2 Agonists with Functional Microglial ActivitySemantic proximity Read

TREM2 Activation by First-in-Class Direct Small Molecule Agonists: DEL Screening, Optimization, Biophysical Validation, and Functional CharacterizationSemantic proximity Read

Small Molecule Agonists of TREM2 Reprogram Microglia and Protect Synapses in Human Alzheimer’s ModelsSemantic proximity Read

Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer’s disease ligandsSemantic proximity Read

Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple AD ligandsSemantic proximity Read

Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer's and Nasu-Hakola disease.Semantic proximity Read

Evaluating the pathogenicity, stability, and stereochemical effects of variants of unknown significance in TREM2 using orthogonal structural analysesSemantic proximity Read

Aβ-Overlapping Ectodomain Binding of the Clinical-Stage TREM2 Agonist VG-3927Semantic proximity Read

AI-Guided Design of Cyclic Peptide Binders Targeting TREM2 Using CycleRFdiffusion and Experimental ValidationSemantic proximity Read

Selection and structural characterisation of anti-TREM2 scFvs that reduce levels of shed ectodomainSemantic proximity Read

Building a potent TREM2 agonistic, biparatopic, common light chain antibodySemantic proximity Read